Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer

por Mace, Thomas, Shakya, Reena, Pitarresi, Jason, Loftus, Shannon, Swanson, Benjamin, Young, Gregory, Zhong, Xioling, Zimmers, Teresa, Ostrowski, Michael, Ludwig, Thomas, Bloomston, Mark, Bekaii-Saab, Tanios, Lesinski, Gregory
Publicado 2015